Regulatory PathRegulatory requirements compared

Active substances

Bacitracin + Neomycin + Polymyxin b + Zinc oxide

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
MULTICIN-Z OINTMENTOintment · Topical1 TubeSAR 7.75NCE · OTCARAB CENTER FOR PHARMACEUTICALS & CHEMICAL IND. CO.Withdrawn by regulatory authority · Not Marketed
MULTICIN-Z POWDERCutaneous powder · Topical1 BottleSAR 3.90NCE · OTCARAB CENTER FOR PHARMACEUTICALS & CHEMICAL IND. CO.Withdrawn by regulatory authority · Not Marketed

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.